Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antimuscarinic
Unknown mechanism in CNS; reduces vertigo
|
Tachycardia, blurred vision, xerostomia, delirium
|
Prevention of motion sickness and postoperative nausea and vomiting
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antimuscarinic
Competitive antagonism at all M receptors; causes mydriasis and cyclopegia (paralysis of ciliary muscle), long duration (5-6 days)
|
Increased intraocular pressure in glaucoma
|
Retinal examination; prevention of synechiae (adhesion of iris to cornea or lens) after surgery
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antimuscarinic
Like atropine but shorter duration of action (15-60 min)
|
Blurred vision
|
Retinal examination
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antimuscarinic
Competitive, nonselective antagonist at M receptors, inhibits bronchoconstriction by Vagus n.
|
Xerostemia, cough
|
Prevention and relief of acute bronchospasm; COPD bronchodilator
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antimuscarinic
Nonselective muscarinic antagonist, reduces detrusor smooth muscle tone
|
Tachycardia, constipation, increased intraocular pressure, xerostemia
|
Relieve bladder spasm after urologic surgery (prostatectomy); urge incontinence
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Antinicotinic - Ganglion Blocker
Nondepolarizing competitive N receptor antagonist; crosses blood-brain barrier and enters CNS
|
Sedation, tremor, choreiform movements, mental aberrations
|
Formerly used for hypertension, now sometimes used for smoking cessation
|
|
|
|
Term
|
Definition
CH 8 Cholinoceptor-Blocking Drugs
Cholinesterase Regenerator
High affinity for phosphorous atom but does not enter CNS; binds to organophosphate-inactivated acetylcholinesterase and removes organophosphate
|
Muscle weakness in overdose
|
Antidote for early stage cholinesterase inhibitor poisoning
|
|
|
|